{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:42:05Z","timestamp":1792730525673,"version":"4.5.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Geriatr Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Both heart failure and its treatment with diuretics or SGLT2 inhibitors increase fall risk in older adults. Therefore, decisions to continue or deprescribe diuretics or SGLT2 inhibitors in older heart failure patients who have fallen are generally highly complex and challenging for clinicians. However, a comprehensive overview of information required for rationale and safe decision-making is lacking. The aim of this clinical review was to assist clinicians in safe (de)prescribing of these drug classes in older heart failure patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We comprehensively searched and summarized published literature and international guidelines on the efficacy, fall-related safety issues, and deprescribing of the commonly prescribed diuretics and SGLT2 inhibitors in older adults.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Both diuretics and SGLT2 inhibitors potentially cause various fall-related adverse effects. Their fall-related side effect profiles partly overlap (e.g., tendency to cause hypotension), but there are also important differences; based on the currently available evidence of this relatively new drug class, SGLT2 inhibitors seem to have a favorable fall-related adverse effect profile compared to diuretics (e.g., low\/absent tendency to cause hyperglycemia or electrolyte abnormalities, low risk of worsening chronic kidney disease). In addition, SGLT2 inhibitors have potential beneficial effects (e.g., disease-modifying effects in heart failure, renoprotective effects), whereas diuretic effects are merely symptomatic.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>(De)prescribing diuretics and SGLT2 inhibitors in older heart failure patients who have fallen is often highly challenging, but this clinical review paper assists clinicians in individualized and patient-centered rational clinical decision-making: we provide a summary of available literature on efficacy and (subclass-specific) safety profiles of diuretics and SGLT2 inhibitors, and practical guidance on safe (de)prescribing of these drugs (e.g. a clinical decision tree for deprescribing diuretics in older adults who have fallen).<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s41999-023-00752-7","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T03:04:19Z","timestamp":1675393459000},"page":"659-674","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Diuretics, SGLT2 inhibitors and falls in older heart failure patients: to prescribe or to deprescribe? A clinical review"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2021-5602","authenticated-orcid":false,"given":"Eveline P.","family":"van Poelgeest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Louis","family":"Handoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majon","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"van der Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On behalf of the EUGMS Task & Finish group on Fall-risk-increasing drugs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,3]]},"reference":[{"key":"752_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afac205","author":"M Montero-Odasso","year":"2022","unstructured":"Montero-Odasso M, van der Velde N, Martin FC et al (2022) World guidelines for falls prevention and management for older adults: a global initiative. Age Ageing. https:\/\/doi.org\/10.1093\/ageing\/afac205","journal-title":"Age Ageing"},{"key":"752_CR2","unstructured":"Promotion EAfIPaS (2022) Falls among adults in the EU28: key facts from the available statistics (https:\/\/eupha.org\/repository\/sections\/ipsp\/Factsheet_falls_in_older_adults_in_EU.pdf)"},{"issue":"3","key":"752_CR3","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/TA.0b013e3181f6f5e5","volume":"71","author":"KA Hartholt","year":"2011","unstructured":"Hartholt KA, van Beeck EF, Polinder S et al (2011) Societal consequences of falls in the older population: injuries, healthcare costs, and long-term reduced quality of life. J Trauma-Injury Infect Crit Care 71(3):748\u2013753. https:\/\/doi.org\/10.1097\/TA.0b013e3181f6f5e5","journal-title":"J Trauma-Injury Infect Crit Care"},{"issue":"3","key":"752_CR4","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/ehf2.12651","volume":"7","author":"EEF Kleipool","year":"2020","unstructured":"Kleipool EEF, Wiersinga JHI, Trappenburg MC et al (2020) The relevance of a multidomain geriatric assessment in older patients with heart failure. Esc Heart Fail 7(3):1264\u20131272. https:\/\/doi.org\/10.1002\/ehf2.12651","journal-title":"Esc Heart Fail"},{"issue":"3","key":"752_CR5","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1002\/ehf2.13292","volume":"8","author":"JHI Wiersinga","year":"2021","unstructured":"Wiersinga JHI, Rhodius-Meester HFM, Kleipool EEF et al (2021) Managing older patients with heart failure calls for a holistic approach. Esc Heart Fail 8(3):2111\u20132119. https:\/\/doi.org\/10.1002\/ehf2.13292","journal-title":"Esc Heart Fail"},{"issue":"2","key":"752_CR6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s41999-020-00435-7","volume":"12","author":"A Ungar","year":"2021","unstructured":"Ungar A, Rivasi G, Petrovic M et al (2021) Toward a geriatric approach to patients with advanced age and cardiovascular diseases: position statement of the EuGMS Special Interest Group on Cardiovascular Medicine (vol 11, pg 179, 2020). Eur Geriatr Med 12(2):429\u2013429. https:\/\/doi.org\/10.1007\/s41999-020-00435-7","journal-title":"Eur Geriatr Med"},{"issue":"17","key":"752_CR7","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/j.jacc.2018.02.059","volume":"71","author":"EZ Gorodeski","year":"2018","unstructured":"Gorodeski EZ, Goyal P, Hummel SL et al (2018) Domain management approach to heart failure in the geriatric patient present and future. J Am Coll Cardiol 71(17):1921\u20131936. https:\/\/doi.org\/10.1016\/j.jacc.2018.02.059","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"752_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/jgs.16157","volume":"68","author":"P Goyal","year":"2020","unstructured":"Goyal P, Anderson TS, Bernacki GM et al (2020) Physician perspectives on deprescribing cardiovascular medications for older adults. J Am Geriatr Soc 68(1):78\u201386. https:\/\/doi.org\/10.1111\/jgs.16157","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"752_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.jamda.2015.08.022","volume":"17","author":"S Jansen","year":"2016","unstructured":"Jansen S, Bhangu J, de Rooij S, Daams J, Kenny RA, van der Velde N (2016) The association of cardiovascular disorders and falls: a systematic review. J Am Med Dir Assoc 17(3):193\u2013199. https:\/\/doi.org\/10.1016\/j.jamda.2015.08.022","journal-title":"J Am Med Dir Assoc"},{"issue":"12","key":"752_CR10","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1016\/S0002-9149(00)00795-5","volume":"85","author":"DJW van Kraaij","year":"2000","unstructured":"van Kraaij DJW, Jansen RWMM, Bouwels LHR, Gribnau FWJ, Hoefnagels WHL (2000) Furosemide withdrawal in elderly heart failure patients with preserved left ventricular systolic function. Am J Cardiol 85(12):1461\u20131466. https:\/\/doi.org\/10.1016\/S0002-9149(00)00795-5","journal-title":"Am J Cardiol"},{"issue":"7106","key":"752_CR11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/bmj.315.7106.464","volume":"315","author":"EP Walma","year":"1997","unstructured":"Walma EP, Hoes AW, van Dooren C, Prins A, van der Does E (1997) Withdrawal of long term diuretic medication in elderly patients: a double blind randomised trial. Bmj-Brit Med J 315(7106):464\u2013468. https:\/\/doi.org\/10.1136\/bmj.315.7106.464","journal-title":"Bmj-Brit Med J"},{"issue":"9","key":"752_CR12","doi-asserted-by":"publisher","first-page":"E561","DOI":"10.1016\/S2666-7568(21)00170-7","volume":"2","author":"V Kosjerina","year":"2021","unstructured":"Kosjerina V, Carstensen B, Jorgensen ME et al (2021) Discontinuation of diabetes medication in the 10 years before death in Denmark: a register-based study. Lancet Health Longev 2(9):E561\u2013E570. https:\/\/doi.org\/10.1016\/S2666-7568(21)00170-7","journal-title":"Lancet Health Longev"},{"issue":"36","key":"752_CR13","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599\u20133726. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"issue":"2","key":"752_CR14","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ejhf.1369","volume":"21","author":"W Mullens","year":"2019","unstructured":"Mullens W, Damman K, Harjola VP et al (2019) The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 21(2):137\u2013155. https:\/\/doi.org\/10.1002\/ejhf.1369","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"752_CR15","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/eurheartj\/ehi176","volume":"26","author":"S Gupta","year":"2005","unstructured":"Gupta S, Neyses L (2005) Diuretic usage in heart failure: a continuing conundrum in 2005. Eur Heart J 26(7):644\u2013649. https:\/\/doi.org\/10.1093\/eurheartj\/ehi176","journal-title":"Eur Heart J"},{"key":"752_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-021-10149-y","author":"J Beezer","year":"2021","unstructured":"Beezer J, Al Hatrushi M, Husband A, Kurdi A, Forsyth P (2021) Polypharmacy definition and prevalence in heart failure: a systematic review (Jul, 10.1007\/s10741-021-10135-4, 2021). Heart Fail Rev. https:\/\/doi.org\/10.1007\/s10741-021-10149-y","journal-title":"Heart Fail Rev"},{"issue":"1","key":"752_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10741-018-9735-7","volume":"24","author":"J Simonavicius","year":"2019","unstructured":"Simonavicius J, Knackstedt C, Brunner-La Rocca HP (2019) Loop diuretics in chronic heart failure: how to manage congestion? Heart Fail Rev 24(1):17\u201330. https:\/\/doi.org\/10.1007\/s10741-018-9735-7","journal-title":"Heart Fail Rev"},{"issue":"16","key":"752_CR18","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","volume":"385","author":"SD Anker","year":"2021","unstructured":"Anker SD, Butler J, Filippatos G et al (2021) Empagliflozin in heart failure with a preserved ejection fraction. New Engl J Med 385(16):1451\u20131461. https:\/\/doi.org\/10.1056\/NEJMoa2107038","journal-title":"New Engl J Med"},{"issue":"6","key":"752_CR19","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/eurheartj\/ehaa1012","volume":"42","author":"J Bauersachs","year":"2021","unstructured":"Bauersachs J (2021) Heart failure drug treatment: the fantastic four. Eur Heart J 42(6):681\u2013683. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa1012","journal-title":"Eur Heart J"},{"issue":"10244","key":"752_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(20)30748-0","volume":"396","author":"M Vaduganathan","year":"2020","unstructured":"Vaduganathan M, Claggett BL, Jhund PS et al (2020) Estimating lifetime benefits of comprehensive disease -modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials. Lancet 396(10244):121\u2013128. https:\/\/doi.org\/10.1016\/S0140-6736(20)30748-0","journal-title":"Lancet"},{"issue":"5","key":"752_CR21","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s13300-021-01035-9","volume":"12","author":"WD Strain","year":"2021","unstructured":"Strain WD, Down S, Brown P, Puttanna A, Sinclair A (2021) Diabetes and frailty: an expert consensus statement on the management of older adults with type 2 diabetes. Diabetes Ther 12(5):1227\u20131247. https:\/\/doi.org\/10.1007\/s13300-021-01035-9","journal-title":"Diabetes Ther"},{"issue":"5\u20136","key":"752_CR22","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.jjcc.2017.12.004","volume":"71","author":"M Sano","year":"2018","unstructured":"Sano M (2018) A new class of drugs for heart failure: SGLT2 inhibitors reduce sympathetic overactivity. J Cardiol May-Jun 71(5\u20136):471\u2013476. https:\/\/doi.org\/10.1016\/j.jjcc.2017.12.004","journal-title":"J Cardiol May-Jun"},{"key":"752_CR23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.059725","author":"MN Kosiborod","year":"2022","unstructured":"Kosiborod MN, Angermann CE, Collins SP et al (2022) Effects of empagliflozin on symptoms, physical limitations and quality of life in patients hospitalized for acute heart failure - results from the EMPULSE trial. Circulation. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.059725","journal-title":"Circulation"},{"issue":"4","key":"752_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.11909\/j.issn.1671-5411.2018.04.011","volume":"15","author":"C Gulla","year":"2018","unstructured":"Gulla C, Flo E, Kjome RL, Husebo BS (2018) Deprescribing antihypertensive treatment in nursing home patients and the effect on blood pressure. J Geriatr Cardiol 15(4):275\u2013283. https:\/\/doi.org\/10.11909\/j.issn.1671-5411.2018.04.011","journal-title":"J Geriatr Cardiol"},{"issue":"5","key":"752_CR25","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00228-020-03052-2","volume":"77","author":"BA Damoiseaux-Volman","year":"2021","unstructured":"Damoiseaux-Volman BA, Medlock S, Raven K et al (2021) Potentially inappropriate prescribing in older hospitalized Dutch patients according to the STOPP\/START criteria v2: a longitudinal study. Eur J Clin Pharmacol 77(5):777\u2013785. https:\/\/doi.org\/10.1007\/s00228-020-03052-2","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"752_CR26","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1001\/jamainternmed.2019.7087","volume":"180","author":"RD Savage","year":"2020","unstructured":"Savage RD, Visentin JD, Bronskill SE et al (2020) Evaluation of a common prescribing cascade of calcium channel blockers and diuretics in older adults with hypertension. JAMA Intern Med 180(5):643\u2013651. https:\/\/doi.org\/10.1001\/jamainternmed.2019.7087","journal-title":"JAMA Intern Med"},{"key":"752_CR27","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.15447","author":"SM Vouri","year":"2022","unstructured":"Vouri SM, Morris EJ, Wang GHM, Bilal AHJ, Hallas J, Henriksen DP (2022) Association between gabapentinoids and oedema treated with loop diuretics: A pooled sequence symmetry analysis from the USA and Denmark. Brit J Clin Pharmaco. https:\/\/doi.org\/10.1111\/bcp.15447","journal-title":"Brit J Clin Pharmaco"},{"issue":"11","key":"752_CR28","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1161\/Circulationaha.120.045691","volume":"142","author":"M Griffin","year":"2020","unstructured":"Griffin M, Rao VS, Ivey-Miranda J et al (2020) Empagliflozin in heart failure diuretic and cardiorenal effects. Circulation 142(11):1028\u20131039. https:\/\/doi.org\/10.1161\/Circulationaha.120.045691","journal-title":"Circulation"},{"key":"752_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afac201","author":"M Evans","year":"2022","unstructured":"Evans M, Morgan AR, Davies S, Beba H, Strain WD (2022) The role of sodium-glucose co-transporter-2 inhibitors in frail older adults with or without type 2 diabetes mellitus. Age Ageing. https:\/\/doi.org\/10.1093\/ageing\/afac201","journal-title":"Age Ageing"},{"issue":"10","key":"752_CR30","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1007\/s00125-018-4663-6","volume":"61","author":"BC Lupsa","year":"2018","unstructured":"Lupsa BC, Inzucchi SE (2018) Use of SGLT2 inhibitors in type 2 diabetes: weighing the risks and benefits. Diabetologia 61(10):2118\u20132125. https:\/\/doi.org\/10.1007\/s00125-018-4663-6","journal-title":"Diabetologia"},{"issue":"11","key":"752_CR31","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.2215\/Cjn.09840819","volume":"14","author":"DH Ellison","year":"2019","unstructured":"Ellison DH (2019) Clinical pharmacology in diuretic use (vol 14, pg 1248, 2019). Clin J Am Soc Nephro 14(11):1653\u20131654. https:\/\/doi.org\/10.2215\/Cjn.09840819","journal-title":"Clin J Am Soc Nephro"},{"issue":"1","key":"752_CR32","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/00000441-200001000-00004","volume":"319","author":"DC Brater","year":"2000","unstructured":"Brater DC (2000) Pharmacology of diuretics. Am J Med Sci 319(1):38\u201350. https:\/\/doi.org\/10.1097\/00000441-200001000-00004","journal-title":"Am J Med Sci"},{"issue":"3","key":"752_CR33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ahj.2014.12.009","volume":"169","author":"J Buggey","year":"2015","unstructured":"Buggey J, Mentz RJ, Pitt B et al (2015) A reappraisal of loop diuretic choice in heart failure patients. Am Heart J 169(3):323\u2013333. https:\/\/doi.org\/10.1016\/j.ahj.2014.12.009","journal-title":"Am Heart J"},{"issue":"6","key":"752_CR34","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1517\/phgs.4.6.701.22817","volume":"4","author":"SV Vormfelde","year":"2003","unstructured":"Vormfelde SV, Burckhardt G, Zirk A, Wojnowski L, Brockmoller J (2003) Pharmacogenomics of diuretic drugs: data on rare monogenic disorders and on polymorphisms and requirements for further research. Pharmacogenomics 4(6):701\u2013734. https:\/\/doi.org\/10.1517\/phgs.4.6.701.22817","journal-title":"Pharmacogenomics"},{"issue":"9","key":"752_CR35","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1177\/2047487320923185","volume":"28","author":"EF Veenis","year":"2021","unstructured":"Veenis EF, Brunner-La Rocca HP, Linssen GCM et al (2021) Impact of sex-specific target dose in chronic heart failure patients with reduced ejection fraction. Eur J Prev Cardiol 28(9):957\u2013965","journal-title":"Eur J Prev Cardiol"},{"issue":"5","key":"752_CR36","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1159\/000471494","volume":"45","author":"BF Palmer","year":"2017","unstructured":"Palmer BF, Clegg DJ (2017) Thiazide-associated hyponatremia: a major dilemma affecting treatment. Am J Nephrol 45(5):417\u2013419. https:\/\/doi.org\/10.1159\/000471494","journal-title":"Am J Nephrol"},{"issue":"1","key":"752_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s40265-014-0337-y","volume":"75","author":"AJ Scheen","year":"2015","unstructured":"Scheen AJ (2015) Pharmacodynamics, efficacy and safety of sodium-glucose co-transporter type 2 (SGLT2) inhibitors for the treatment of type 2 diabetes mellitus. Drugs 75(1):33\u201359. https:\/\/doi.org\/10.1007\/s40265-014-0337-y","journal-title":"Drugs"},{"issue":"6","key":"752_CR38","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s40266-020-00757-y","volume":"37","author":"JS Custodio","year":"2020","unstructured":"Custodio JS, Roriz J, Cavalcanti CAJ, Martins A, Salles JEN (2020) Use of SGLT2 inhibitors in older adults: scientific evidence and practical aspects. Drug Aging 37(6):399\u2013409. https:\/\/doi.org\/10.1007\/s40266-020-00757-y","journal-title":"Drug Aging"},{"key":"752_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-016-0789-4","author":"AJ Scheen","year":"2016","unstructured":"Scheen AJ (2016) SGLT2 inhibitors: benefit\/risk balance. Curr Diabetes Rep. https:\/\/doi.org\/10.1007\/s11892-016-0789-4","journal-title":"Curr Diabetes Rep."},{"issue":"4","key":"752_CR40","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1093\/ajh\/hpx189","volume":"31","author":"HR Kahlaee","year":"2018","unstructured":"Kahlaee HR, Latt MD, Schneider CR (2018) Association between chronic or acute use of antihypertensive class of medications and falls in older adults a systematic review and meta-analysis. Am J Hypertens 31(4):467\u2013479. https:\/\/doi.org\/10.1093\/ajh\/hpx189","journal-title":"Am J Hypertens"},{"issue":"6","key":"752_CR41","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jchf.2014.05.014","volume":"2","author":"PM McKie","year":"2014","unstructured":"McKie PM, Schirger JA, Benike SL, Harstad LK, Chen HH (2014) The effects of dose reduction of furosemide on glomerular filtration rate in stable systolic heart failure. Jacc-Heart Fail 2(6):675\u2013677. https:\/\/doi.org\/10.1016\/j.jchf.2014.05.014","journal-title":"Jacc-Heart Fail"},{"issue":"5","key":"752_CR42","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.ejheart.2004.09.006","volume":"7","author":"E Galve","year":"2005","unstructured":"Galve E, Mallol A, Catalan R et al (2005) Clinical and neurohumoral consequences of diuretic withdrawal in patients with chronic, stabilized heart failure and systolic dysfunction. Eur J Heart Fail 7(5):892\u2013898. https:\/\/doi.org\/10.1016\/j.ejheart.2004.09.006","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"752_CR43","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"TA McDonagh","year":"2022","unstructured":"McDonagh TA, Metra M, Adamo M et al (2022) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 24(1):4\u2013131. https:\/\/doi.org\/10.1002\/ejhf.2333","journal-title":"Eur J Heart Fail"},{"key":"752_CR44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ijcard.2017.10.018","volume":"250","author":"P Martens","year":"2018","unstructured":"Martens P, Verbrugge FH, Boonen L, Nijst P, Dupont M, Mullens W (2018) Value of routine investigations to predict loop diuretic down-titration success in stable heart failure. Int J Cardiol 250:171\u2013175. https:\/\/doi.org\/10.1016\/j.ijcard.2017.10.018","journal-title":"Int J Cardiol"},{"issue":"6","key":"752_CR45","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.jamda.2013.02.002","volume":"14","author":"M Wehling","year":"2013","unstructured":"Wehling M (2013) Morbus diureticus in the elderly: epidemic overuse of a widely applied group of drugs. J Am Med Dir Assoc 14(6):437\u2013442. https:\/\/doi.org\/10.1016\/j.jamda.2013.02.002","journal-title":"J Am Med Dir Assoc"},{"issue":"4","key":"752_CR46","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1053\/j.ajkd.2020.05.014","volume":"76","author":"VS Sridhar","year":"2020","unstructured":"Sridhar VS, Tuttle KR, Cherney DZI (2020) We can finally stop worrying about SGLT2 inhibitors and acute kidney injury. Am J Kidney Dis 76(4):454\u2013456. https:\/\/doi.org\/10.1053\/j.ajkd.2020.05.014","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"752_CR47","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1161\/Circulationaha.121.052792","volume":"145","author":"IE Beldhuis","year":"2022","unstructured":"Beldhuis IE, Lam CSP, Testani JM et al (2022) Evidence-based medical therapy in patients with heart failure with reduced ejection fraction and chronic kidney disease. Circulation 145(9):693\u2013712. https:\/\/doi.org\/10.1161\/Circulationaha.121.052792","journal-title":"Circulation"},{"issue":"5","key":"752_CR48","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/ckj\/sfz100","volume":"12","author":"JH Li","year":"2019","unstructured":"Li JH, Fagbote CO, Zhuo M, Hawley CE, Paik JM (2019) Sodium-glucose cotransporter 2 inhibitors for diabetic kidney disease: a primer for deprescribing. Clin Kidney J 12(5):620\u2013628. https:\/\/doi.org\/10.1093\/ckj\/sfz100","journal-title":"Clin Kidney J"},{"issue":"8","key":"752_CR49","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1080\/17512433.2018.1500896","volume":"11","author":"A Correa","year":"2018","unstructured":"Correa A, Rochlani Y, Khan MH, Aronow WS (2018) Pharmacological management of hypertension in the elderly and frail populations. Expert Rev Clin Phar 11(8):805\u2013817. https:\/\/doi.org\/10.1080\/17512433.2018.1500896","journal-title":"Expert Rev Clin Phar"},{"issue":"12","key":"752_CR50","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.2215\/CJN.10140620","volume":"15","author":"G Bakris","year":"2020","unstructured":"Bakris G, Oshima M, Mahaffey KW et al (2020) Effects of canagliflozin in patients with baseline eGFR < 30 ml\/min per 1.73 m(2) subgroup analysis of the randomized CREDENCE trial. Clin J Am Soc Nephro 15(12):1705\u20131714","journal-title":"Clin J Am Soc Nephro"},{"issue":"9","key":"752_CR51","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1681\/Asn.2021020167","volume":"32","author":"GM Chertow","year":"2021","unstructured":"Chertow GM, Vart P, Jongs N et al (2021) Effects of dapagliflozin in stage 4 chronic kidney disease. J Am Soc Nephrol 32(9):2352\u20132361. https:\/\/doi.org\/10.1681\/Asn.2021020167","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"752_CR52","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s12325-021-01994-2","volume":"39","author":"CW Mende","year":"2022","unstructured":"Mende CW (2022) Chronic kidney disease and SGLT2 inhibitors: a review of the evolving treatment landscape. Adv Ther 39(1):148\u2013164. https:\/\/doi.org\/10.1007\/s12325-021-01994-2","journal-title":"Adv Ther"},{"issue":"2","key":"752_CR53","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/ejcn.2014.195","volume":"69","author":"T Tachi","year":"2015","unstructured":"Tachi T, Yokoi T, Goto C et al (2015) Hyponatremia and hypokalemia as risk factors for falls. Eur J Clin Nutr 69(2):205\u2013210. https:\/\/doi.org\/10.1038\/ejcn.2014.195","journal-title":"Eur J Clin Nutr"},{"key":"752_CR54","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afaa249","author":"LJ Seppala","year":"2020","unstructured":"Seppala LJ, Petrovic M, Ryg J et al (2020) STOPPFall (Screening Tool of Older Persons Prescriptions in older adults with high fall risk): a Delphi study by the eugms task and finish group on fall-risk-increasing drugs. Age Ageing. https:\/\/doi.org\/10.1093\/ageing\/afaa249","journal-title":"Age Ageing"},{"issue":"12","key":"752_CR55","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.jchf.2017.10.007","volume":"5","author":"FH Messerli","year":"2017","unstructured":"Messerli FH, Rimoldi SF, Bangalore S (2017) The transition from hypertension to heart failure: contemporary update (vol 5, 543, 2017). Jacc-Heart Fail 5(12):948\u2013948. https:\/\/doi.org\/10.1016\/j.jchf.2017.10.007","journal-title":"Jacc-Heart Fail"},{"issue":"10","key":"752_CR56","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s40266-020-00796-5","volume":"37","author":"G Rivasi","year":"2020","unstructured":"Rivasi G, Rafanelli M, Mossello E, Brignole M, Ungar A (2020) Drug-related orthostatic hypotension: beyond anti-hypertensive medications. Drug Aging 37(10):725\u2013738. https:\/\/doi.org\/10.1007\/s40266-020-00796-5","journal-title":"Drug Aging"},{"issue":"7","key":"752_CR57","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/gerona\/glp028","volume":"64","author":"C Mussi","year":"2009","unstructured":"Mussi C, Ungar A, Salvioli G et al (2009) Orthostatic hypotension as cause of syncope in patients older than 65 years admitted to emergency departments for transient loss of consciousness. J Gerontol a-Biol 64(7):801\u2013806. https:\/\/doi.org\/10.1093\/gerona\/glp028","journal-title":"J Gerontol a-Biol"},{"issue":"5","key":"752_CR58","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/EDE.0b013e3181e89905","volume":"21","author":"S Deandrea","year":"2010","unstructured":"Deandrea S, Lucenteforte E, Bravi F, Foschi R, La Vecchia C, Negri E (2010) Risk factors for falls in community-dwelling older people a systematic review and meta-analysis. Epidemiology 21(5):658\u2013668. https:\/\/doi.org\/10.1097\/EDE.0b013e3181e89905","journal-title":"Epidemiology"},{"issue":"7","key":"752_CR59","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1161\/Circresaha.118.313236","volume":"124","author":"A Benetos","year":"2019","unstructured":"Benetos A, Petrovic M, Strandberg T (2019) Hypertension management in older and frail older patients. Circ Res 124(7):1045\u20131060. https:\/\/doi.org\/10.1161\/Circresaha.118.313236","journal-title":"Circ Res"},{"issue":"24","key":"752_CR60","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1001\/jama.2016.7050","volume":"315","author":"JD Williamson","year":"2016","unstructured":"Williamson JD, Supiano MA, Applegate WB et al (2016) Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged >\/=75 years: a randomized clinical trial. JAMA 315(24):2673\u20132682. https:\/\/doi.org\/10.1001\/jama.2016.7050","journal-title":"JAMA"},{"issue":"9","key":"752_CR61","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1001\/jamainternmed.2017.2924","volume":"177","author":"DJ Sexton","year":"2017","unstructured":"Sexton DJ, Canney M, O\u2019Connell MDL et al (2017) Injurious Falls and syncope in older community-dwelling adults meeting inclusion criteria for SPRINT. JAMA Intern Med 177(9):1385\u20131387. https:\/\/doi.org\/10.1001\/jamainternmed.2017.2924","journal-title":"JAMA Intern Med"},{"issue":"6","key":"752_CR62","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/ageing\/afv141","volume":"44","author":"G Ogliari","year":"2015","unstructured":"Ogliari G, Westendorp RGJ, Muller M et al (2015) Blood pressure and 10-year mortality risk in the Milan Geriatrics 75+Cohort Study: role of functional and cognitive status. Age Ageing 44(6):932\u2013937. https:\/\/doi.org\/10.1093\/ageing\/afv141","journal-title":"Age Ageing"},{"issue":"5","key":"752_CR63","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jamda.2019.01.149","volume":"20","author":"A Ceccofiglio","year":"2019","unstructured":"Ceccofiglio A, Mussi C, Rafanelli M et al (2019) Increasing prevalence of orthostatic hypotension as a cause of syncope with advancing age and multimorbidity. J Am Med Dir Assoc 20(5):586\u2013588. https:\/\/doi.org\/10.1016\/j.jamda.2019.01.149","journal-title":"J Am Med Dir Assoc"},{"issue":"8","key":"752_CR64","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1111\/jgs.14225","volume":"64","author":"A Ungar","year":"2016","unstructured":"Ungar A, Mussi C, Ceccofiglio A et al (2016) Etiology of syncope and unexplained falls in elderly adults with dementia: syncope and dementia (SYD) study. J Am Geriatr Soc 64(8):1567\u20131573. https:\/\/doi.org\/10.1111\/jgs.14225","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"752_CR65","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/ageing\/afv199","volume":"45","author":"JE Moonen","year":"2016","unstructured":"Moonen JE, Foster-Dingley JC, de Ruijter W, van der Grond J, de Craen AJ, van der Mast RC (2016) Effect of discontinuation of antihypertensive medication on orthostatic hypotension in older persons with mild cognitive impairment: the DANTE Study Leiden. Age Ageing 45(2):249\u2013255. https:\/\/doi.org\/10.1093\/ageing\/afv199","journal-title":"Age Ageing"},{"issue":"1","key":"752_CR66","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/oxfordjournals.bmb.a072393","volume":"46","author":"CG Swift","year":"1990","unstructured":"Swift CG (1990) Pharmacodynamics - changes in homeostatic mechanisms, receptor and target organ sensitivity in the elderly. Brit Med Bull 46(1):36\u201352. https:\/\/doi.org\/10.1093\/oxfordjournals.bmb.a072393","journal-title":"Brit Med Bull"},{"key":"752_CR67","unstructured":"Ishani A (2022) Chlorthalidone compared with hydrochlorothiazide for the prevention of cardiovascular events in patients with hypertension: the Diuretic Comparison Project (DCP). Presented at the AHA Conference on November 5, 2022 (Late breaking science session)"},{"key":"752_CR68","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-physiol-031620-095920","volume":"83","author":"V Vallon","year":"2021","unstructured":"Vallon V, Verma S (2021) Effects of SGLT2 inhibitors on kidney and cardiovascular function. Annu Rev Physiol 83:503\u2013528. https:\/\/doi.org\/10.1146\/annurev-physiol-031620-095920","journal-title":"Annu Rev Physiol"},{"issue":"7","key":"752_CR69","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/hr.2017.14","volume":"40","author":"T Yoshikawa","year":"2017","unstructured":"Yoshikawa T, Kishi T, Shinohara K et al (2017) Arterial pressure lability is improved by sodium-glucose cotransporter 2 inhibitor in streptozotocin-induced diabetic rats. Hypertens Res 40(7):646\u2013651. https:\/\/doi.org\/10.1038\/hr.2017.14","journal-title":"Hypertens Res"},{"issue":"8","key":"752_CR70","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1097\/Hjh.0000000000002088","volume":"37","author":"M Burnier","year":"2019","unstructured":"Burnier M, Bakris G, Williams B (2019) Redefining diuretics use in hypertension: why select a thiazide-like diuretic? J Hypertens 37(8):1574\u20131586. https:\/\/doi.org\/10.1097\/Hjh.0000000000002088","journal-title":"J Hypertens"},{"issue":"1","key":"752_CR71","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/art.38203","volume":"66","author":"S Bruderer","year":"2014","unstructured":"Bruderer S, Bodmer M, Jick SS, Meier CR (2014) Use of diuretics and risk of incident gout a population-based case-control study. Arthritis Rheumatol 66(1):185\u2013196. https:\/\/doi.org\/10.1002\/art.38203","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"752_CR72","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11556-011-0086-9","volume":"9","author":"P Levinger","year":"2012","unstructured":"Levinger P, Wallman S, Hill K (2012) Balance dysfunction and falls in people with lower limb arthritis: factors contributing to risk and effectiveness of exercise interventions. Eur Rev Aging Phys A 9(1):17\u201325. https:\/\/doi.org\/10.1007\/s11556-011-0086-9","journal-title":"Eur Rev Aging Phys A"},{"issue":"7","key":"752_CR73","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s40266-021-00866-2","volume":"38","author":"M Kumar","year":"2021","unstructured":"Kumar M, Manley N, Mikuls TR (2021) Gout flare burden, diagnosis, and management: navigating care in older patients with comorbidity. Drug Aging 38(7):545\u2013557. https:\/\/doi.org\/10.1007\/s40266-021-00866-2","journal-title":"Drug Aging"},{"issue":"18","key":"752_CR74","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1161\/Circulationaha.118.037076","volume":"139","author":"K Kario","year":"2019","unstructured":"Kario K, Okada K, Kato M et al (2019) Twenty-four-hour blood pressure-lowering effect of a sodium-glucose cotransporter 2 inhibitor in patients with diabetes and uncontrolled nocturnal hypertension results from the randomized, placebo-controlled SACRA study. Circulation 139(18):2089\u20132097. https:\/\/doi.org\/10.1161\/Circulationaha.118.037076","journal-title":"Circulation"},{"key":"752_CR75","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-022-01866-3","author":"M Banerjee","year":"2022","unstructured":"Banerjee M, Pal R, Mukhopadhyay S (2022) Can SGLT2 inhibitors prevent incident gout? A systematic review and meta-analysis. Acta Diabetol. https:\/\/doi.org\/10.1007\/s00592-022-01866-3","journal-title":"Acta Diabetol"},{"issue":"3","key":"752_CR76","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2165\/11596000-000000000-00000","volume":"35","author":"MFWV Herwaarden","year":"2012","unstructured":"Herwaarden MFWV, Kramers C, Sturkenboom MC, van den Bemt PMLA, De Smet PAGM (2012) Targeting outpatient drug safety recommendations of the Dutch HARM-Wrestling task force. Drug Saf 35(3):245\u2013259. https:\/\/doi.org\/10.2165\/11596000-000000000-00000","journal-title":"Drug Saf"},{"issue":"3","key":"752_CR77","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s41999-021-00475-7","volume":"12","author":"EP van Poelgeest","year":"2021","unstructured":"van Poelgeest EP, Pronk AC, Rhebergen D, van der Velde N (2021) Depression, antidepressants and fall risk: therapeutic dilemmas-a clinical review. Eur Geriatr Med 12(3):585\u2013596. https:\/\/doi.org\/10.1007\/s41999-021-00475-7","journal-title":"Eur Geriatr Med"},{"issue":"3","key":"752_CR78","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1681\/asn.2014121196","volume":"27","author":"H Fujisawa","year":"2016","unstructured":"Fujisawa H, Sugimura Y, Takagi H et al (2016) Chronic hyponatremia causes neurologic and psychologic impairments. J Am Soc Nephrol 27(3):766\u2013780. https:\/\/doi.org\/10.1681\/asn.2014121196","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"752_CR79","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017045","volume":"7","author":"EA Fehlberg","year":"2017","unstructured":"Fehlberg EA, Lucero RJ, Weaver MT et al (2017) Associations between hyponatraemia, volume depletion and the risk of falls in US hospitalised patients: a case-control study. BMJ Open 7(8):e017045. https:\/\/doi.org\/10.1136\/bmjopen-2017-017045","journal-title":"BMJ Open"},{"issue":"1","key":"752_CR80","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/ejhf.2008","volume":"23","author":"T Jaarsma","year":"2021","unstructured":"Jaarsma T, Hill L, Bayes-Genis A et al (2021) Self-care of heart failure patients: practical management recommendations from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 23(1):157\u2013174. https:\/\/doi.org\/10.1002\/ejhf.2008","journal-title":"Eur J Heart Fail"},{"issue":"48","key":"752_CR81","doi-asserted-by":"publisher","first-page":"4891","DOI":"10.1093\/eurheartj\/ehab497","volume":"42","author":"BL Neuen","year":"2021","unstructured":"Neuen BL, Oshima M, Perkovic V et al (2021) Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial. Eur Heart J 42(48):4891. https:\/\/doi.org\/10.1093\/eurheartj\/ehab497","journal-title":"Eur Heart J"},{"issue":"11","key":"752_CR82","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.jacc.2021.01.044","volume":"77","author":"JP Ferreira","year":"2021","unstructured":"Ferreira JP, Zannad F, Pocock SJ et al (2021) Interplay of mineralocorticoid receptor antagonists and empagliflozin in heart failure. J Am Coll Cardiol 77(11):1397\u20131407. https:\/\/doi.org\/10.1016\/j.jacc.2021.01.044","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"752_CR83","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.amjmed.2021.04.007","volume":"134","author":"S Ravioli","year":"2021","unstructured":"Ravioli S, Bahmad S, Funk GC, Schwarz C, Exadaktylos A, Lindner G (2021) Risk of electrolyte disorders, syncope, and falls in patients taking thiazide diuretics: results of a cross-sectional study. Am J Med 134(9):1148\u20131154. https:\/\/doi.org\/10.1016\/j.amjmed.2021.04.007","journal-title":"Am J Med"},{"key":"752_CR84","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l35","author":"SD Anisman","year":"2019","unstructured":"Anisman SD, Erickson SB, Morden NE (2019) How to prescribe loop diuretics in oedema. Bmj-Brit Med J. https:\/\/doi.org\/10.1136\/bmj.l35","journal-title":"Bmj-Brit Med J."},{"issue":"11","key":"752_CR85","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1002\/pds.4636","volume":"27","author":"BCT Kieboom","year":"2018","unstructured":"Kieboom BCT, Zietse R, Ikram MA, Hoorn EJ, Stricker BH (2018) Thiazide but not loop diuretics is associated with hypomagnesaemia in the general population. Pharmacoepidem Dr S 27(11):1166\u20131173. https:\/\/doi.org\/10.1002\/pds.4636","journal-title":"Pharmacoepidem Dr S"},{"key":"752_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.829","author":"G Liamis","year":"2021","unstructured":"Liamis G, Hoorn EJ, Florentin M, Milionis H (2021) An overview of diagnosis and management of drug-induced hypomagnesemia. Pharmacol Res Perspe. https:\/\/doi.org\/10.1002\/prp2.829","journal-title":"Pharmacol Res Perspe"},{"issue":"4","key":"752_CR87","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1093\/ajh\/hpy036","volume":"31","author":"AP Cai","year":"2018","unstructured":"Cai AP, Calhoun DA (2018) Antihypertensive Medications and Falls in the Elderly (vol 31, pg 281, 2018). Am J Hypertens 31(4):513\u2013513. https:\/\/doi.org\/10.1093\/ajh\/hpy036","journal-title":"Am J Hypertens"},{"issue":"1","key":"752_CR88","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2165\/00002512-200522010-00004","volume":"22","author":"H Hajjar","year":"2005","unstructured":"Hajjar H (2005) Postural blood pressure changes and orthostatic hypotension in the elderly patient - Impact of antihypertensive medications. Drug Aging 22(1):55\u201368","journal-title":"Drug Aging"},{"issue":"8","key":"752_CR89","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1007\/s00392-021-01822-1","volume":"110","author":"N Marcks","year":"2021","unstructured":"Marcks N, Aimo A, Januzzi JL et al (2021) Re-appraisal of the obesity paradox in heart failure: a meta-analysis of individual data. Clin Res Cardiol 110(8):1280\u20131291. https:\/\/doi.org\/10.1007\/s00392-021-01822-1","journal-title":"Clin Res Cardiol"},{"issue":"4","key":"752_CR90","first-page":"222","volume":"7","author":"RT Frederick","year":"2011","unstructured":"Frederick RT (2011) Current concepts in the pathophysiology and management of hepatic encephalopathy. Gastroenterol Hepatol (N Y) 7(4):222\u2013233","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"12","key":"752_CR91","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1177\/0091270006292126","volume":"46","author":"RM Carnahan","year":"2006","unstructured":"Carnahan RM, Lund BC, Perry PJ, Pollock BG, Culp KR (2006) The anticholinergic drug scale as a measure of drug-related anticholinergic burden: Associations with serum anticholinergic activity. J Clin Pharmacol 46(12):1481\u20131486. https:\/\/doi.org\/10.1177\/0091270006292126","journal-title":"J Clin Pharmacol"},{"key":"752_CR92","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003178.pub2","volume":"1","author":"DR Salvador","year":"2004","unstructured":"Salvador DR, Rey NR, Ramos GC, Punzalan FE (2004) Continuous infusion versus bolus injection of loop diuretics in congestive heart failure. Cochrane Database Syst Rev 1:CD003178. https:\/\/doi.org\/10.1002\/14651858.CD003178.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"752_CR93","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2015-009522","volume":"5","author":"M Torstensson","year":"2015","unstructured":"Torstensson M, Hansen AH, Leth-Moller K et al (2015) Danish register-based study on the association between specific cardiovascular drugs and fragility fractures. BMJ Open 5(12):e009522","journal-title":"BMJ Open"},{"issue":"2","key":"752_CR94","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00198-012-2053-3","volume":"24","author":"SD Berry","year":"2013","unstructured":"Berry SD, Zhu Y, Choi H, Kiel DP, Zhang Y (2013) Diuretic initiation and the acute risk of hip fracture. Osteoporosis Int 24(2):689\u2013695. https:\/\/doi.org\/10.1007\/s00198-012-2053-3","journal-title":"Osteoporosis Int"},{"issue":"2","key":"752_CR95","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00198-012-2053-3","volume":"24","author":"SD Berry","year":"2013","unstructured":"Berry SD, Zhu Y, Choi H, Kiel DP, Zhang Y (2013) Diuretic initiation and the acute risk of hip fracture. Osteoporos Int 24(2):689\u2013695. https:\/\/doi.org\/10.1007\/s00198-012-2053-3","journal-title":"Osteoporos Int"},{"issue":"5","key":"752_CR96","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1111\/j.1532-5415.2009.02195.x","volume":"57","author":"LS Lim","year":"2009","unstructured":"Lim LS, Fink HA, Blackwell T, Taylor BC, Ensrud KE (2009) Loop diuretic use and rates of hip bone loss and risk of falls and fractures in older women. J Am Geriatr Soc 57(5):855\u2013862. https:\/\/doi.org\/10.1111\/j.1532-5415.2009.02195.x","journal-title":"J Am Geriatr Soc"},{"issue":"11","key":"752_CR97","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1007\/s40266-015-0306-5","volume":"32","author":"G Corrao","year":"2015","unstructured":"Corrao G, Mazzola P, Compagnoni MM et al (2015) Antihypertensive medications, loop diuretics, and risk of hip fracture in the elderly: a population-based cohort study of 81,617 Italian patients newly treated between 2005 and 2009. Drug Aging 32(11):927\u2013936. https:\/\/doi.org\/10.1007\/s40266-015-0306-5","journal-title":"Drug Aging"},{"issue":"10","key":"752_CR98","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.30762","volume":"4","author":"M Zhuo","year":"2021","unstructured":"Zhuo M, Hawley CE, Paik JM et al (2021) Association of sodium-glucose cotransporter-2 inhibitors with fracture risk in older adults with type 2 diabetes. Jama Netw Open 4(10):e2130762","journal-title":"Jama Netw Open"},{"key":"752_CR99","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.3389\/fphar.2018.01517","volume":"9","author":"YL Ye","year":"2019","unstructured":"Ye YL, Zhao CH, Liang J, Yang YQ, Yu MX, Qu XH (2019) Effect of sodium-glucose co-transporter 2 inhibitors on bone metabolism and fracture risk. Front Pharmacol 9:1517","journal-title":"Front Pharmacol"},{"issue":"11","key":"752_CR100","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.jamda.2018.06.021","volume":"19","author":"H Dills","year":"2018","unstructured":"Dills H, Shah K, Messinger-Rapport B, Bradford K, Syed Q (2018) Deprescribing medications for chronic diseases management in primary care settings: a systematic review of randomized controlled trials. J Am Med Dir Assoc 19(11):923\u2013935. https:\/\/doi.org\/10.1016\/j.jamda.2018.06.021","journal-title":"J Am Med Dir Assoc"},{"issue":"12","key":"752_CR101","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.2165\/0002512-200825120-00004","volume":"25","author":"S Iyer","year":"2008","unstructured":"Iyer S, Naganathan V, McLachlan AJ, Le Couteur DG (2008) Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging 25(12):1021\u20131031. https:\/\/doi.org\/10.2165\/0002512-200825120-00004","journal-title":"Drugs Aging"},{"issue":"675","key":"752_CR102","doi-asserted-by":"publisher","first-page":"E663","DOI":"10.3399\/bjgp18X699041","volume":"68","author":"SL Thio","year":"2018","unstructured":"Thio SL, Nam J, van Driel ML, Dirven T, Blom JW (2018) Effects of discontinuation of chronic medication in primary care: a systematic review of deprescribing trials. Brit J Gen Pract 68(675):E663\u2013E672. https:\/\/doi.org\/10.3399\/bjgp18X699041","journal-title":"Brit J Gen Pract"},{"issue":"1","key":"752_CR103","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/ehf2.13742","volume":"9","author":"AR de Boer","year":"2022","unstructured":"de Boer AR, Vaartjes I, Gohar A et al (2022) Heart failure with preserved, mid-range, and reduced ejection fraction across health care settings: an observational study. Esc Heart Fail 9(1):363\u2013372. https:\/\/doi.org\/10.1002\/ehf2.13742","journal-title":"Esc Heart Fail"},{"issue":"1","key":"752_CR104","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/ageing\/6.1.38","volume":"6","author":"ML Burr","year":"1977","unstructured":"Burr ML, King S, Davies HE, Pathy MS (1977) The effects of discontinuing long-term diuretic therapy in the elderly. Age Ageing 6(1):38\u201345. https:\/\/doi.org\/10.1093\/ageing\/6.1.38","journal-title":"Age Ageing"},{"issue":"12","key":"752_CR105","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/0002-9149(94)90815-X","volume":"73","author":"WC Grinstead","year":"1994","unstructured":"Grinstead WC, Francis MJ, Marks GF, Tawa CB, Zoghbi WA, Young JB (1994) Discontinuation of chronic diuretic therapy in stable congestive-heart-failure secondary to coronary-artery disease or to idiopathic dilated cardiomyopathy. Am J Cardiol 73(12):881\u2013886","journal-title":"Am J Cardiol"},{"issue":"2","key":"752_CR106","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s13167-018-0137-7","volume":"9","author":"N Davarzani","year":"2018","unstructured":"Davarzani N, Sanders-van Wijk S, Maeder MT et al (2018) Novel concept to guide systolic heart failure medication by repeated biomarker testing-results from TIME-CHF in context of predictive, preventive, and personalized medicine. EPMA J 9(2):161\u2013173. https:\/\/doi.org\/10.1007\/s13167-018-0137-7","journal-title":"EPMA J"},{"issue":"7","key":"752_CR107","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1111\/jgs.17204","volume":"69","author":"P Navid","year":"2021","unstructured":"Navid P, Nguyen L, Jaber D et al (2021) Attitudes toward deprescribing among adults with heart failure with preserved ejection fraction. J Am Geriatr Soc 69(7):1948\u20131955. https:\/\/doi.org\/10.1111\/jgs.17204","journal-title":"J Am Geriatr Soc"},{"issue":"8","key":"752_CR108","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1111\/j.1532-5415.2008.01800.x","volume":"56","author":"ME Tinetti","year":"2008","unstructured":"Tinetti ME (2008) Multifactorial fall-prevention strategies: Time to retreat or advance. J Am Geriatr Soc 56(8):1563\u20131565. https:\/\/doi.org\/10.1111\/j.1532-5415.2008.01800.x","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"752_CR109","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1177\/1060028016637181","volume":"50","author":"CH Luymes","year":"2016","unstructured":"Luymes CH, van der Kleij RM, Poortvliet RK, de Ruijter W, Reis R, Numans ME (2016) Deprescribing Potentially Inappropriate Preventive Cardiovascular Medication: Barriers and Enablers for Patients and General Practitioners. Ann Pharmacother 50(6):446\u2013454. https:\/\/doi.org\/10.1177\/1060028016637181","journal-title":"Ann Pharmacother"},{"issue":"7","key":"752_CR110","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1002\/ejhf.2145","volume":"23","author":"J Dauw","year":"2021","unstructured":"Dauw J, Martens P, Tersalvi G et al (2021) Diuretic response and effects of diuretic omission in ambulatory heart failure patients on chronic low-dose loop diuretic therapy. Eur J Heart Fail 23(7):1110\u20131119. https:\/\/doi.org\/10.1002\/ejhf.2145","journal-title":"Eur J Heart Fail"},{"key":"752_CR111","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.5090","author":"PJ Kennel","year":"2021","unstructured":"Kennel PJ, Rosenblum H, Axsom KM et al (2021) Remote cardiac monitoring in patients with heart failure a review. Jama Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2021.5090","journal-title":"Jama Cardiol"},{"issue":"6","key":"752_CR112","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1111\/jgs.16369","volume":"68","author":"LA Hart","year":"2020","unstructured":"Hart LA, Phelan EA, Yi JLY, Marcum ZA, Gray SL (2020) Use of fall risk-increasing drugs around a fall-related injury in older adults: a systematic review. J Am Geriatr Soc 68(6):1334\u20131343. https:\/\/doi.org\/10.1111\/jgs.16369","journal-title":"J Am Geriatr Soc"}],"container-title":["European Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-023-00752-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41999-023-00752-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-023-00752-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T16:01:48Z","timestamp":1692806508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41999-023-00752-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":112,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["752"],"URL":"https:\/\/doi.org\/10.1007\/s41999-023-00752-7","relation":{},"ISSN":["1878-7657"],"issn-type":[{"value":"1878-7657","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,3]]},"assertion":[{"value":"30 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}